🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the efficacy, safety of Hetromb...
Status
Completed
Location
Beijing children's hospital .Capital medical university
Start Date
2021-03-29
Trial ID
NCT04737850
Treatments Being Tested
The purpose of current study is to evaluate the efficacy and safety of hetr...
Status
Active Not Recruiting
Location
Hematology Tumor Research Center of Harbin First Hospital
Start Date
2023-04-25
Trial ID
NCT05864014
Treatments Being Tested
A multicentre, randomised, double-blind,4-stages phase III study enrolled 4...
Status
Completed
Location
Union Hospital Tongji Medical College Huazhong University of Science and technology
Start Date
2017-06-30
Trial ID
NCT03222843
Treatments Being Tested
Randomized, double-blind, placebo-controlled study to evaluate the efficacy...
Status
Completed
Location
Najing Bayi Hospital
Start Date
2019-11-06
Trial ID
NCT03976882
Treatments Being Tested
This investigator-initiated, prospective, multicenter, open-label, randomiz...
Status
Unknown
Location
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Start Date
2023-01-01
Trial ID
NCT05727917
Treatments Being Tested
This is a multicenter, placebo-control, phase 3 study of hetrombopag in pat...
Status
Active Not Recruiting
Location
Blood Diseases Hospital, Chinese Academy of Medical Sciences
Start Date
2019-09-19
Trial ID
NCT04961710
Treatments Being Tested
This is a single center, randomized, controlled study, to evaluate the effi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2022-07-25
Trial ID
NCT05442632
Treatments Being Tested
The study is being conducted to evaluate the efficacy, and safety of of Het...
Status
Recruiting
Location
Cancer and Blood Specialty Clinic
Start Date
2026-04-16
Trial ID
NCT07286032
Treatments Being Tested